Approval · Notice of Compliance 9882 · 2008
THALLIUM: Notice of Compliance 9882
Issued November 7, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9882
- Date
- November 7, 2008
- Company
- Lantheus Mi Canada IncMontreal, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Diagnostic agent for intravenous use
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| THALLIUM | Not yet assigned | — |
Medicinal ingredients
- THALLIUM CHLORIDE (TI 201) 2 MCI per ML
- THALLIUM CHLORIDE (TI 201) 1 MCI per ML